Santa Cruz Biotechnology offers a broad range of β-lactamase monoclonal antibodies for research in understanding antibiotic resistance mechanisms. β-lactamase monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). β-lactamases are enzymes produced by bacteria that confer resistance to β-lactam antibiotics, such as penicillins and cephalosporins, by hydrolyzing the antibiotic's β-lactam ring. The study of β-lactamases is crucial for developing new therapeutic strategies and understanding the dynamics of antibiotic resistance in clinical settings. By studying β-lactamase, researchers can gain insights into bacterial survival mechanisms and the evolution of resistance. Understanding β-lactamase function helps identify potential therapeutic targets and develop more effective antibiotics. Research into β-lactamase mechanisms continues to reveal new aspects of bacterial antibiotic resistance. β-lactamase monoclonal antibodies from Santa Cruz Biotechnology enable researchers worldwide to advance scientific understanding of antibiotic resistance and develop innovative therapeutic solutions.